Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!


Subscribe to our channel on YouTube!  YouTube  




Study Confirms Transave’s Antibiotic May Reduce Pseudomonas

April 3, 2008

Transave Inc., a biopharmaceutical company focused on developing inhaled therapies for lung diseases, reported today that its lead product candidate, ARIKACE™ (liposomal amikacin for inhalation), may have the ability to penetrate mucus and decrease the number of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis, according to a study published in the April issue of the Journal of Antimicrobial Chemotherapy

The Cystic Fibrosis Foundation provided a $1.7 million award for this clinical program.

Read the full press release.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.